MEMPHIS, Tenn. (WMC) – A new therapy may bring hope to those with a difficult-to-treat form of lung cancer.
The disease is known as ROS1-positive (ROS1+), a type of non-small cell lung cancer that is aggressive and frequently spreads to the brain.
Joining Action News 5′s Digital Desk to talk about a new FDA-approved treatment option are Dr. Jason Porter, Thoracic Medical Oncologist at West Cancer Center and Janet Freeman-Daily, co-founder and president of The ROS1ders
Click here to sign up for our newsletter!
Click here to report a spelling or grammar error. Please include the headline.
Copyright 2024 WMC. All rights reserved.